John L Cameron
Overview
Explore the profile of John L Cameron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
296
Citations
21186
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hill C, Parkinson R, Jaffee E, Sugar E, Zheng L, Onners B, et al.
Int J Radiat Oncol Biol Phys
. 2024 Nov;
121(4):930-941.
PMID: 39547453
Purpose: Local and distant progression remains common following resection of resectable pancreatic ductal adenocarcinoma (PDAC) despite adjuvant multiagent chemotherapy. We report a prospective institutional phase 1 trial incorporating adjuvant GVAX...
2.
Nicolson N, Tandurella J, Wu L, Patel J, Morris E, Seppala T, et al.
Ann Surg
. 2024 Sep;
PMID: 39229726
Objective: We integrate a new approach to chemosensitivity data for clinically-relevant regimen matching, and demonstrate the relationship with clinical outcomes in a large PDO biobank. Summary Background Data: Pancreatic ductal...
3.
Kinny-Koster B, Ahmad Y, Pfluger M, Habib J, Fujikura K, Hutchings D, et al.
Pancreas
. 2024 Jun;
53(6):e528-e536.
PMID: 38888841
Objectives: Although prevalent in 50%-90% of pancreatic ductal adenocarcinomas, the clinical relevance of "cancerization of ducts" (COD) remains unknown. Methods: Pathologists retrospectively reviewed slides classifying prevalence of COD. Histopathological parameters,...
4.
Wu A, Thompson E, Cameron J, He J, Burkhart R, Burns W, et al.
Am J Surg Pathol
. 2024 Mar;
48(6):726-732.
PMID: 38482693
The radiologic finding of focal stenosis of the main pancreatic duct is highly suggestive of pancreatic cancer. Even in the absence of a mass lesion, focal duct stenosis can lead...
5.
Chang Wu B, Wlodarczyk J, Nourmohammadi Abadchi S, Shababi N, Cameron J, Harmon J
eGastroenterology
. 2024 Jan;
1(2).
PMID: 38292831
The History Maker paper focuses on the extraordinary revolution that dramatically improved the surgical results for the Whipple procedure (pancreaticoduodenectomy) in the 1980s and identifies Dr. Cameron as the leader...
6.
Purchla J, Ghabi E, Burns W, Lafaro K, Burkhart R, Cameron J, et al.
J Am Coll Surg
. 2024 Jan;
238(4):532-540.
PMID: 38189646
Background: Molecular profiling of intrahepatic cholangiocarcinoma (ICC) can detect actionable molecular alterations and guide targeted therapies. We explore the clinical use of molecular profiling of ICC in our comprehensive multidisciplinary...
7.
Ghabi E, Habib J, Shoucair S, Javed A, Sham J, Burns W, et al.
Ann Surg Oncol
. 2023 Jul;
30(12):7720-7730.
PMID: 37488390
Background: Pancreatic neuroendocrine tumors (PanNETs) exhibit heterogenous behavior, whereby some small tumors are aggressive with a propensity for metastasis. Detection of somatic mutations associated with aggressive biology may help with...
8.
Rowe S, Fishman E, Chu L, Johnson P, Cameron J
Curr Probl Diagn Radiol
. 2023 Jul;
52(5):313-314.
PMID: 37438230
Objective: Dr. John L. Cameron was appointed the chair of surgery at Johns Hopkins in 1984. He subsequently built the largest group of clinician-scientists anywhere in the world who were...
9.
Nagai M, Wright M, Ding D, Thompson E, Javed A, Weiss M, et al.
J Hepatobiliary Pancreat Sci
. 2023 Jan;
30(8):1025-1035.
PMID: 36652559
Background: Patients with pancreatic ductal adenocarcinoma (PDAC) and liver metastasis are treated with palliative chemotherapy, whereas similar patients with metastatic colorectal cancer are considered for aggressive surgery. Methods: Using an...
10.
Resected Early-Onset Pancreatic Cancer: Practices and Outcomes in an International Dual-Center Study
Leonhardt C, Kinny-Koster B, Hank T, Habib J, Shoucair S, Klaiber U, et al.
Ann Surg Oncol
. 2022 Dec;
30(4):2433-2443.
PMID: 36479659
Background: Early-onset pancreatic cancer (EOPC), defined as age ≤ 45 years at diagnosis, accounts for 3% of all pancreatic cancer cases. Although differences in tumor biology have been suggested, available...